Wells Fargo’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $223M | Buy |
4,657,642
+1,015,043
| +28% | +$43.6M | 0.04% | 395 |
|
|
2026
Q1 | $134M | Sell |
3,642,599
-349,450
| -9% | -$16.6M | 0.03% | 525 |
|
|
2025
Q4 | $203M | Sell |
3,992,049
-114,314
| -3% | -$5.85M | 0.04% | 374 |
|
|
2025
Q3 | $228M | Sell |
4,106,363
-65,260
| -2% | -$3.82M | 0.04% | 344 |
|
|
2025
Q2 | $288M | Buy |
4,171,623
+378,810
| +10% | +$25.8M | 0.06% | 276 |
|
|
2025
Q1 | $263M | Buy |
3,792,813
+119,698
| +3% | +$9.89M | 0.06% | 281 |
|
|
2024
Q4 | $316M | Sell |
3,673,115
-395,739
| -10% | -$42.8M | 0.07% | 240 |
|
|
2024
Q3 | $484M | Sell |
4,068,854
-17,702
| -0.4% | -$2.36M | 0.11% | 171 |
|
|
2024
Q2 | $583M | Buy |
4,086,556
+132,556
| +3% | +$17.6M | 0.14% | 145 |
|
|
2024
Q1 | $508M | Buy |
3,954,000
+154,751
| +4% | +$18.4M | 0.12% | 160 |
|
|
2023
Q4 | $393M | Buy |
3,799,249
+122,484
| +3% | +$12.1M | 0.1% | 190 |
|
|
2023
Q3 | $334M | Buy |
3,676,765
+335,613
| +10% | +$29.6M | 0.1% | 200 |
|
|
2023
Q2 | $270M | Buy |
3,341,152
+163,090
| +5% | +$13.3M | 0.07% | 234 |
|
|
2023
Q1 | $253M | Sell |
3,178,062
-24,054
| -0.8% | -$1.71M | 0.07% | 237 |
|
|
2022
Q4 | $217M | Sell |
3,202,116
-4,742
| -0.1% | -$278K | 0.07% | 257 |
|
|
2022
Q3 | $160M | Sell |
3,206,858
-367,774
| -10% | -$19.7M | 0.05% | 301 |
|
|
2022
Q2 | $199M | Buy |
3,574,632
+181,714
| +5% | +$10.1M | 0.06% | 271 |
|
|
2022
Q1 | $188M | Buy |
3,392,918
+353,054
| +12% | +$18.1M | 0.05% | 312 |
|
|
2021
Q4 | $170M | Sell |
3,039,864
-34,770
| -1% | -$1.88M | 0.04% | 325 |
|
|
2021
Q3 | $148M | Buy |
3,074,634
+23,354
| +0.8% | +$1.13M | 0.03% | 494 |
|
|
2021
Q2 | $128M | Sell |
3,051,280
-464,412
| -13% | -$18M | 0.03% | 559 |
|
|
2021
Q1 | $119M | Buy |
3,515,692
+182,910
| +5% | +$6.51M | 0.03% | 584 |
|
|
2020
Q4 | $116M | Buy |
3,332,782
+118,572
| +4% | +$4.1M | 0.03% | 572 |
|
|
2020
Q3 | $112M | Buy |
3,214,210
+346,386
| +12% | +$11.5M | 0.03% | 514 |
|
|
2020
Q2 | $93.9M | Sell |
2,867,824
-18,556
| -0.6% | -$592K | 0.03% | 569 |
|
|
2020
Q1 | $86.9M | Buy |
2,886,380
+41,934
| +1% | +$1.25M | 0.03% | 508 |
|
|
2019
Q4 | $82.3M | Sell |
2,844,446
-18,578
| -0.6% | -$514K | 0.02% | 684 |
|
|
2019
Q3 | $74M | Buy |
2,863,024
+21,930
| +0.8% | +$555K | 0.02% | 717 |
|
|
2019
Q2 | $72.5M | Buy |
2,841,094
+58,964
| +2% | +$1.46M | 0.02% | 740 |
|
|
2019
Q1 | $72.8M | Buy |
2,782,130
+201,564
| +8% | +$4.95M | 0.02% | 709 |
|
|
2018
Q4 | $59.4M | Sell |
2,580,566
-109,808
| -4% | -$2.44M | 0.02% | 738 |
|
|
2018
Q3 | $63.4M | Buy |
2,690,374
+86,506
| +3% | +$2.11M | 0.02% | 802 |
|
|
2018
Q2 | $60M | Buy |
2,603,868
+319,238
| +14% | +$7.59M | 0.02% | 821 |
|
|
2018
Q1 | $56.3M | Sell |
2,284,630
-382,548
| -14% | -$10M | 0.02% | 844 |
|
|
2017
Q4 | $71.6M | Sell |
2,667,178
-2,492
| -0.1% | -$63.4K | 0.02% | 720 |
|
|
2017
Q3 | $64.3M | Sell |
2,669,670
-362,032
| -12% | -$8.18M | 0.02% | 746 |
|
|
2017
Q2 | $65M | Sell |
3,031,702
-147,512
| -5% | -$2.98M | 0.02% | 733 |
|
|
2017
Q1 | $54.5M | Buy |
3,179,214
+66,754
| +2% | +$1.16M | 0.02% | 812 |
|
|
2016
Q4 | $55.8M | Sell |
3,112,460
-2,572,910
| -45% | -$46.6M | 0.02% | 778 |
|
|
2016
Q3 | $118M | Sell |
5,685,370
-871,176
| -13% | -$21.6M | 0.04% | 450 |
|
|
2016
Q2 | $176M | Buy |
6,556,546
+3,149,910
| +92% | +$86.4M | 0.07% | 309 |
|
|
2016
Q1 | $92.3M | Sell |
3,406,636
-58,326
| -2% | -$1.56M | 0.04% | 500 |
|
|
2015
Q4 | $101M | Sell |
3,464,962
-147,536
| -4% | -$4.08M | 0.04% | 466 |
|
|
2015
Q3 | $98M | Buy |
3,612,498
+142,764
| +4% | +$4.04M | 0.04% | 471 |
|
|
2015
Q2 | $95M | Buy |
3,469,734
+120,142
| +4% | +$3.38M | 0.04% | 517 |
|
|
2015
Q1 | $89.4M | Buy |
3,349,592
+95,466
| +3% | +$2.2M | 0.03% | 526 |
|
|
2014
Q4 | $68.9M | Sell |
3,254,126
-630,334
| -16% | -$14.1M | 0.03% | 613 |
|
|
2014
Q3 | $92.6M | Sell |
3,884,460
-145,230
| -4% | -$3.34M | 0.04% | 469 |
|
|
2014
Q2 | $93.1M | Buy |
4,029,690
+152,784
| +4% | +$3.37M | 0.04% | 499 |
|
|
2014
Q1 | $88.5M | Sell |
3,876,906
-715,154
| -16% | -$15.2M | 0.04% | 512 |
|
|
2013
Q4 | $84.8M | Buy |
4,592,060
+1,054,960
| +30% | +$18.4M | 0.04% | 510 |
|
|
2013
Q3 | $59.9M | Buy |
3,537,100
+227,040
| +7% | +$3.82M | 0.03% | 607 |
|
|
2013
Q2 | $51.3M | Buy |
+3,310,060
| New | +$55.1M | 0.03% | 624 |
|
Other funds holding NVO
F
Wells Fargo's NVO Position: Q2 2026 in Review
Wells Fargo increased its Novo Nordisk (NVO) stake by 28% in Q2 2026, buying an estimated $43.6M and bringing the position to 4,657,642 shares worth $223M. The position accounts for 0.04% of the portfolio, ranked #395.
Wells Fargo first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $583M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Wells Fargo held 4,657,642 shares of Novo Nordisk worth $223M as of Q2 2026.
- Wells Fargo bought 1,015,043 Novo Nordisk shares in Q2 2026, an estimated $43.6M.
- Novo Nordisk made up 0.04% of Wells Fargo's portfolio in Q2 2026, its #395 holding.
- Wells Fargo first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Novo Nordisk position peaked at $583M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.